Browsing by Author Tsimihodimos, V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 50 to 69 of 74 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Milionis, H.; Bairaktari, E.; Tzallas, C.; Miltiadous, G.; Katsaraki, A.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinicTsimihodimos, V.; Bairaktari, E.; Tzallas, C.; Miltiadus, G.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profileFilippatos, T. D.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased serum ferritin concentrations and liver enzyme activities in patients with metabolic syndromeTsimihodimos, V.; Gazi, I.; Kalaitzidis, R.; Elisaf, M. S.; Siamopoulos, K. C.24-Nov-2015-
Iron overload: An additional feature of the metabolic syndrome?Kalogirou, G.; Tsimihodimos, V.; Kalaitzidis, R.; Bairaktari, E.; Siamopoulos, K.; Elisaf, M. S.; Seferiadis, K.24-Nov-2015-
Is therapy with statins effective in patients with homozygous familial hypercholesterolaemiaElisaf, M. E.; Miltiadous, G.; Xenophontos, S.; Tsimihodimos, V.; Tselepis, A.; Cariolou, M.; Papathanasiou, A.; Goudevenos, I.24-Nov-2015-
LDL cholesterol estimation in patients with the metabolic syndromeGazi, I.; Tsimihodimos, V.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Lipoprotein glomerulopathyTsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemiaMiltiadous, G.; Tsimihodimos, V.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Lipoprotein-associated phospholipase A(2) activity is a marker of small, dense LDL particles in human plasmaGazi, I.; Lourida, E. S.; Filippatos, T.; Tsimihodimos, V.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particlesGazi, I.; Lourida, E.; Filippatos, T.; Tsimihodimos, V.; Saougos, V.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic ProfileFilippatos, T.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Pleiotropic effects of ezetimibe: do they really exist?Kalogirou, M.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Pleiotropic effects of fenofibrateTsimihodimos, V.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activityKakafika, A. I.; Xenofontos, S.; Tsimihodimos, V.; Tambaki, A. P.; Lourida, E. S.; Kalaitzidis, R.; Cariolou, M. A.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Possible mechanisms of the fibrate-induced increase in serum creatinineTsimihodimos, V.; Miltiadous, G.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Prediabetes: to treat or not to treat?Moutzouri, E.; Tsimihodimos, V.; Rizos, E.; Elisaf, M. S.24-Nov-2015-
Reduced levels of HDL-associated PAF-acetylhydrolase activity in normolipidemic and dyslipidemic PON1 55LL carriersKakafika, A.; Tambaki, A.; Lourida, E.; Xenofontos, S.; Tsimihodimos, V.; Kalaitzidis, R.; Cariolou, M.; Elisaf, M.; Tselepis, A.24-Nov-2015-